Chronic lymphocytic leukemia disease progression is accelerated by APRIL-TACI interaction in the TCL1 transgenic mouse model

Blood

Volumn 122, Issue 24, 2013, Pages 3960-3963

  Lascano, Valeria ^a   Guadagnoli, Marco ^a   Schot, Jan G ^a   Luijks, Dieuwertje M ^a   Guikema, Jeroen E J ^a   Cameron, Katherine ^a   Hahne, Michael ^b   Pals, Steven ^a   Slinger, Erik ^a   Kipps, Thomas J ^c   Van Oers, Marinus H J ^a   Eldering, Eric ^a   Medema, Jan Paul ^a   Kater, Arnon P ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b CNRS   (France)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR; ONCOPROTEIN; PROTEIN BINDING; TCL1 PROTEIN, MOUSE; TNFRSF13B PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CLONAL EVOLUTION; CONTROLLED STUDY; LEUKEMIA CELL; LEUKEMOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; TRANSGENIC MOUSE; ANIMAL; C57BL MOUSE; DISEASE COURSE; DISEASE MODEL; GENETICS; HEK293 CELL LINE; HUMAN; KAPLAN MEIER METHOD; METABOLISM; MUTATION; PATHOLOGY; TIME; TUMOR CELL CULTURE;

ANIMALS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HEK293 CELLS; HUMANS; KAPLAN-MEIER ESTIMATE; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; TIME FACTORS; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR PROTEIN; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13;

EID: 84893502005     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-04-497693     Document Type: Article

References (13)

1. Burger JA, Ghia P, Rosenwald A, Caligaris-Cappio F. The microenvironment in mature B-cell malignancies: a target for new treatment strategies. Blood. 2009;114(16):3367-3375.
2. Smit LA, Hallaert DY, Spijker R, et al. Differential Noxa/Mcl-1 balance in peripheral versus lymph node chronic lymphocytic leukemia cells correlates with survival capacity. Blood. 2007; 109(4):1660-1668.
3. Herishanu Y, Pérez-Galán P, Liu D, et al. The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood. 2011;117(2):563-574.
4. Bossen C, Schneider P. BAFF, APRIL and their receptors: structure, function and signaling. Semin Immunol. 2006;18(5):263-275.
5. Kern C, Cornuel JF, Billard C, et al. Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway. Blood. 2004;103(2):679-688.
6. Nishio M, Endo T, Tsukada N, et al. Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha. Blood. 2005;106(3):1012-1020.
7. Planelles L, Castillo-Gutiérrez S, Medema JP, Morales-Luque A, Merle-Béral H, Hahne M. APRIL but not BLyS serum levels are increased in chronic lymphocytic leukemia: prognostic relevance of APRIL for survival. Haematologica. 2007;92(9):1284-1285.
8. Guadagnoli M, Kimberley FC, Phan U, et al. Development and characterization of APRIL antagonistic monoclonal antibodies for treatment of B-cell lymphomas. Blood. 2011;117(25): 6856-6865.
9. Enzler T, Kater AP, Zhang W, et al. Chronic lymphocytic leukemia of Emu-TCL1 transgenic mice undergoes rapid cell turnover that can be offset by extrinsic CD257 to accelerate disease progression. Blood. 2009;114(20): 4469-4476.
10. Planelles L, Carvalho-Pinto CE, Hardenberg G, et al. APRIL promotes B-1 cell-associated neoplasm. Cancer Cell. 2004;6(4):399-408.
11. Bichi R, Shinton SA, Martin ES, et al. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc Natl Acad Sci USA. 2002;99(10):6955-6960.
12. Kimberley FC, van der Sloot AM, Guadagnoli M, et al. The design and characterization of receptor-selective APRIL variants. J Biol Chem. 2012; 287(44):37434-37446.
13. Fecteau JF, Kipps TJ. Structure and function of the hematopoietic cancer niche: focus on chronic lymphocytic leukemia. Front Biosci (Schol Ed). 2012;4:61-73.